Amid meningitis crisis, critics say Medicare may promote risky drug compounding

NEW YORK, Nov 20 : With 34 deaths and 474 cases of fungal meningitis linked to tainted steroids from a Massachusetts compounding pharmacy, blame has fallen on everyone from the pharmacy to state and federal regulators. Now a new potential culprit has emerged: Medicare, which reimburses for almost all compounded drugs. ‘Medicare’s reimbursement policy is certainly relevant in the government’s role in supporting purchases’ of compounded drugs, Senator Richard Blumenthal told Reuters, referring to the customized medications meant to be prepared for an individual based on doctor directions. (agencies)
^^^^